how long should i stay on glp 1 When to Pause or Stop a GLP-1: A Decision Framework What Should I Expect During
Description
doi:10.1097/01.jcp.0000085423.74359.f2

If yes to multiple questions: GLP-1s target the mechanism

A 50% improvement in ACR50 response, along with a weight reduction of 10% or greater at 36 weeks served as the primary outcome measure

Available from Accessed 1 Mar 2023 Danne T, Garg S, Peters AL et al (2019) International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors

The telehealth GLP-1 boom wouldnt be possible without clinicians willing to write prescriptions for those hundreds of thousands of patients

Notably, compared to the use of GIPR antibodies alone or control antibody-GLP-1 conjugates, GIPR-Ab/GLP-1 exhibits a more potent weight-reducing effect, suggesting a synergistic interaction between the two targeting mechanisms
